[Golenbock Eiseman Assor Bell & Peskoe LLP th 711 Third Avenue, 17 New York, New York 10017 (212) 212-907-7300 April 30, 2020 Re: Origin Agritech Limited. Filed on April 16, 2020 Dear Ms. Paik and Mr. McCann: Registration Statement on Form F-1, Filed April 16, 2020 General 1. We note your Form 6-K fi]
[C O R P O R A T E P A R T I C I P A N T S Hu Xiaoming, Chairman, Chief Executive Officer Kewa Luo, Manager, Investor Relations C O N F E R E N C E C A L L P A R T I C I P A N T S Walter Hill,] []
[This Form 6-K consists of: 1. 2020 an announcement regarding 2. an announcement regarding connected transaction of absorption and merger of Zhanjiang Dongxing; Document 1 ’ (a joint stock limited company incorporated in the People (Stock Code: 00386) China Petroleum & Chemical Corporation The First ]
[CONTENTS] [SPECIMEN * NOT VALID UNLESS COUNTERSIGNED BY TRANSFER AGENT * INCORPORATED UNDER THE LAWS OF THE GOVERNMENT OF ANTIGUA Number Sinovac Shares BIOTECH LTD. This Certifies that Is the Owner of Fully paid and non-assessable shares of Common Stock of Sinovac Biotech Ltd. transferable on the bo]
[CONTENTS] [SPECIMEN * NOT VALID UNLESS COUNTERSIGNED BY TRANSFER AGENT * INCORPORATED UNDER THE LAWS OF THE GOVERNMENT OF ANTIGUA Number Sinovac Shares BIOTECH LTD. This Certifies that Is the Owner of Fully paid and non-assessable shares of Common Stock of Sinovac Biotech Ltd. transferable on the bo]
[C O R P O R A T E P A R T I C I P A N T S Hu Xiaoming, Chairman, Chief Executive Officer Kewa Luo, Manager, Investor Relations C O N F E R E N C E C A L L P A R T I C I P A N T S Walter Hill,] []
[Sinovac Reports Unaudited Fourth Quarter 2019 Financial Results and Files 2019 Annual Report on Form 20-F Fourth Quarter and Full Year 2019 Financial Summary Ÿ Sales for the fourth quarter of 2019 were $81.1 million, an increase of 52.4% from $53.2 million in the prior year period. Ÿ Sales in 2019 w]
[] [Ordinary Shares Type and Class of Securities (Item 9.A.5 of Form 20-F) Preemptive Rights (Item 9.A.3 of Form 20-F) The holders of the Company’s ordinary shares do not have preemptive right. Limitations or Qualifications (Item 9.A.6 of Form 20-F) See “General,” “Voting Rights,” “Conversion of the ]
[The9 Limited Announces Unaudited Financial Information The9 Limited (the “Company”) hereby announces its unaudited consolidated statement of income for the six months ended December 31, 2019 and its unaudited consolidated balance sheet as of December 31, 2019. THE9 LIMITED UNAUDITED CONSOLIDATED STA]
